Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine
Open Access
Abstract
No abstract availableKeywords
Funding Information
- GSK
This publication has 40 references indexed in Scilit:
- Potential impact of a Moraxella catarrhalis vaccine in COPDVaccine, 2019
- Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbationsThorax, 2018
- Pneumococcal vaccination and chronic respiratory diseasesInternational Journal of Chronic Obstructive Pulmonary Disease, 2017
- A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPDThorax, 2017
- Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directionsTranslational Research, 2017
- Global and regional estimates of COPD prevalence: Systematic review and meta–analysisJournal of Global Health, 2015
- COPD ExacerbationsImmunology and Allergy Clinics of North America, 2013
- Outcomes for COPD pharmacological trials: from lung function to biomarkersEuropean Respiratory Journal, 2008
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2002